Skip to main content
. 2020 Oct 15;11:5214. doi: 10.1038/s41467-020-19055-7

Fig. 4. SARS-CoV-2-Nluc-based antiviral screening.

Fig. 4

a Three-day cytotoxicity of chloroquine on Vero E6 and A549-hACE2 cells. b Three-day cytotoxicity of remdesivir on Vero E6 and A549-hACE2 cells. c EC50 of chloroquine against SARS-CoV-2-Nluc on Vero E6 and A549-hACE2 cells. d EC50 of remdesivir against SARS-CoV-2-Nluc on Vero E6 and A549-hACE2 cells. ad Experiments were performed at least twice. Each time, two independent assays were performed. The plots show one of the two experiments performed in duplicates. Each replicate is shown. The four-parameter dose–response curve was fitted using the nonlinear regression method and EC50s were calculated in the software Prism 8. e Summary of CC50, EC50, and selectivity index (SI). The mean ± standard deviations from four independent experiments are indicated. SI = CC50/EC50.